Research institute
The disclosure comes the day before the WHO is expected to plan for the next phase of investigations into the origins of COVID-19.
The tiny heart organoids, dubbed “cardioids,” even begun beating similarly as real miniature hearts, making them the most realistic heart organoids developed to date.
Researchers at John Hopkins made their preliminary conclusions that the vaccines produced by Pfizer-BioNTech and Moderna did not cause the hearing loss.
Forbes highlights its “30 Under 30" list who are beginning to make their mark in the biopharma and healthcare industries.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The FDA further delays Iovance’s filing for its TIL therapy as it requests additional data on the treatment’s potency assays.
A new study from Johns Hopkins University Bloomberg School of Public Health suggests the development of dementia is associated with abnormal levels of plasma proteins, and these proteins may be predictive of dementia up to five years before a patient receives a diagnosis.
Researchers are calling for a “paradigm shift” in indoor ventilation systems to combat COVID-19 and other airborne pathogens.
Sanofi and GSK expect to launch a global pivotal Phase III trial of its COVID-19 vaccine in the coming week.
Although a quiet week for COVID-19-related clinical trial announcements, there were plenty of others. Read on for more information.
PRESS RELEASES